Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
The Breast Journal|August 4, 2009
Rethinking TNM: a breast cancer classification to guide to treatment and facilitate researchUmberto Veronesi, Stefano Zurrida, Giuseppe Viale, et al.Tumori|May 28, 2011
Successful treatment with GEMOX in patient with metastatic pancreatic adenosquamous carcinomaGaetano Aurilio, Teresa Macarulla, Javier Francisco Ramos, et al.JAMA Oncology|July 3, 2025
First-Line Therapy For Advanced Non-Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisFausto Petrelli, Elena Verri, Antonio Ghidini, et al.Breast Cancer Research : BCR|January 19, 2006
Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapyElisabetta Munzone, Giuseppe Curigliano, Andrea Rocca, et al.Future Oncology (London, England)|June 10, 2010
Male breast cancerStefano Zurrida, Franco Nolè, Bernardo Bonanni, et al.European Journal of Cancer (Oxford, England : 1990)|July 15, 2015
The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancerRoberto Iacovelli, Elena Verri, Maria Cossu Rocca, et al.Anti-Cancer Drugs|July 5, 2012
Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?Angela Esposito, Elisabetta Munzone, Vincenzo Bagnardi, et al.The Annals of Pharmacotherapy|October 26, 2006
Erlotinib-induced breast cancer regressionChiara Catania, Tommaso Martino De Pas, Giuseppe Pelosi, et al.Anti-Cancer Drugs|October 28, 2016
Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and treated with first-line tyrosine kinase inhibitorsRoberto Iacovelli, Elena Verri, Maria Cossu Rocca, et al.Cancer Chemotherapy and Pharmacology|February 3, 2009
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancerFranco Nolè, D Crivellari, R Mattioli, et al.Pageof 10